Renal Cell Antibodies

Santa Cruz Biotechnology features a diverse variety of Renal Cell Antibodies for the study of renal cell carcinoma and related kidney functions. Renal Cell Antibodies are compatible with various research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Renal cell carcinoma is a significant type of kidney cancer that arises from the lining of the renal tubules. Understanding the molecular mechanisms and pathways involved in renal cell function and tumorigenesis is crucial for developing targeted therapies and improving patient outcomes. Molecular markers targeted by Renal Cell Antibodies play essential roles in cellular processes such as apoptosis, proliferation, and angiogenesis. Research applications include studying tumor development, progression, and potential therapeutic interventions. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates enable precise visualization and quantification of target proteins. Investigating renal cell markers helps identify novel therapeutic targets and biomarkers for early detection. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of renal cell carcinoma and developing innovative treatment strategies.